The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many questions remain.
Pot stocks rose for the second straight day after the U.S. Department of Health and Human Services recommended that the Drug Enforcement Administration lower the federal classification of cannabis to Schedule III from Schedule I, where it has been since 1970.
Also…
Read the full article here
